CSBR
Champions Oncology Inc
NASDAQ: CSBR · HEALTHCARE · BIOTECHNOLOGY
$5.85
-1.01% today
Updated 2026-04-29
Market cap
$81.45M
P/E ratio
—
P/S ratio
1.41x
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$6 – $10
Volume
0.0M
Champions Oncology Inc (CSBR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-130.6%
Last 4 quarters
Revenue YoY growth
-2.8%
Most recent quarter
EPS YoY growth
-106.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-6.7%
2026-03-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-0.02 | -125.1% | $6.25 | $5.83 | -6.7% |
| 2025-12-15 | $0.06 | +500.0% | $6.72 | $6.73 | +0.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-01-31 | $0.08 | $-0.02 | -125.1% | $16.56M | -2.8% |
| 2025-10-31 | $0.01 | $0.06 | +500.0% | $15.04M | +11.5% |
| 2025-07-31 | $0.06 | $0.02 | -66.7% | $13.99M | -0.5% |
| 2025-04-30 | $0.06 | $-0.07 | -216.7% | $12.36M | -11.8% |
| 2025-01-31 | $-0.01 | $0.33 | +3400.0% | $17.04M | +41.8% |
| 2024-10-31 | $0.01 | $0.05 | +400.0% | $13.49M | +16.6% |
| 2024-07-31 | $-0.03 | $0.11 | +466.7% | $14.06M | +11.9% |
| 2024-04-30 | $-0.16 | $0.01 | +106.3% | $14.00M | +7.1% |
| 2024-01-31 | $-0.06 | $-0.16 | -166.7% | $12.02M | — |
| 2023-10-31 | $-0.17 | $-0.15 | +11.8% | $11.57M | — |
| 2023-07-31 | $-0.10 | $-0.19 | -90.0% | $12.56M | — |
| 2023-04-30 | $-0.12 | $-0.19 | -58.3% | $13.07M | — |
Frequently asked questions
Has Champions Oncology Inc beaten earnings estimates?
Champions Oncology Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -130.6% over the last 3 quarters.
How does CSBR stock react to earnings?
CSBR stock has moved an average of -3.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Champions Oncology Inc's revenue growth rate?
Champions Oncology Inc reported year-over-year revenue growth of -2.8% in its most recent quarter, with EPS growing -106.1% year-over-year.